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ABSTRACT
Objective Tourniquet use in total knee replacement 
(TKR) is believed to improve the bone- cement interface 
by reducing bleeding, potentially prolonging implant 
survival. This study aimed to compare the risk of revision 
for primary cemented TKR performed with or without a 
tourniquet.
Design We analysed data from the National Joint 
Registry (NJR) for all primary cemented TKRs performed 
in England and Wales between April 2003 and December 
2003. Kaplan- Meier plots and Cox regression were used 
to assess the influence of tourniquet use, age at time of 
surgery, sex and American Society of Anaesthesiologists 
(ASA) classification on risk of revision for all- causes.
Results Data were available for 16 974 cases of primary 
cemented TKR, of which 16 132 had surgery with a 
tourniquet and 842 had surgery without a tourniquet. At 
10 years, 3.8% had undergone revision (95% CI 2.6% 
to 5.5%) in the no- tourniquet group and 3.1% in the 
tourniquet group (95% CI 2.8% to 3.4%). After adjusting 
for age at primary surgery, gender and primary ASA score, 
the HR for all- cause revision for cemented TKR without a 
tourniquet was 0.82 (95% CI 0.57 to 1.18).
Conclusions We did not find evidence that using a 
tourniquet for primary cemented TKR offers a clinically 
important or statistically significant reduction in the risk of 
all- cause revision up to 13 years after surgery. Surgeons 
should consider this evidence when deciding whether to 
use a tourniquet for cemented TKR.
BACKGROUND
Total knee replacement (TKR) is widely used 
to relieve pain and improve function for indi-
viduals with end- stage symptomatic arthritis 
of the knee.1 2 In the UK, the majority of TKR 
components are cemented in place to hold 
and stabilise them in the correct position in 
the bone.3 The surgery can be performed 
with or without the use of a thigh tourni-
quet. Survey research has identified that 
most surgeons in the UK and around the 
world perform TKR with the aid of a tour-
niquet and that this practice has remained 
unchanged over time.4–6 In 2003, 93% of 
primary TKRs were performed with a tourni-
quet. A 2015 survey of the British Association 
of Knee Surgeons (BASK) indicated that 90% 
of surgeons routinely use a tourniquet.7 8 The 
reasons for the widespread use of a tourniquet 
include a belief that bleeding bone surfaces 
might impair the fixation of cemented pros-
theses and reduce long- term implant survivor-
ship.7 There are data from laboratory animal 
studies that suggest blood interferes with the 
strength of the bone- cement interface.9 This 
may translate to an increased risk of aseptic 
loosening of the implant components, the 
most common cause of TKR failure neces-
sitating revision surgery.3 However, there is 
also evidence suggesting that tourniquets do 
not improve implant fixation and longevity. 
Two randomised controlled trials (RCTs) in 
humans which used radiostereometric anal-
ysis (RSA — a surrogate marker of long- term 
Strengths and limitations of this study
 ► This is the largest and longest cohort comparing 
revision for all- causes following total knee replace-
ment (TKR) surgery performed with versus without 
a tourniquet.
 ► Approximately 17 000 TKR procedures from 384 
centres were included in this study, enabling gen-
eralisability of our results to similar patient groups.
 ► We have considered all- cause revision as our prima-
ry outcome to mitigate the risk of misclassification 
of indication for revision.
 ► Patients were followed up for a median of 12.2 years 
from their primary procedure, and we have account-
ed for patient death in our analysis.
 ► We could not control for confounding factors includ-
ing tourniquet inflation timing, pressure and duration 
as these details were not collected in the National 
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implant survival) demonstrated no significant differences 
in tibial component migration between TKRs performed 
with versus without tourniquet at up to two years of 
follow- up.10 11
Tourniquet use is not without its risks and has been asso-
ciated with various adverse effects such as increased pain 
and venous thromboembolism.12 They have also been 
associated with other complications including haema-
toma formation, wound discharge, skin injuries and 
nerve palsy, as well as reduced knee range of motion, even 
two years after surgery.4 10 The routine use of tourniquets 
in TKR surgery therefore requires scrutiny to determine 
whether they help to reduce the risk of revision surgery or 
merely expose patients to unnecessary harm.12 This study 
compares the all- cause revision rate between primary 
cemented TKR performed with or without tourniquet. If 
tourniquet use is effective in improving the bone- cement 
interface then lower rates of revision would be observed 
in the tourniquet group.
METHODS
This work forms part of a larger research project titled 
Safety and Feasibility Evaluation of Tourniquets in Knee 
Replacement Surgery (SAFE- TKR) and adhered to the 
published protocol.13 This article reports the findings 
for risk of revision between patients who underwent TKR 
surgery with versus without a thigh tourniquet. Other 
outcomes examining potential adverse events and length 
of hospital will be reported within a separate article.
Data covering England and Wales were provided by the 
NJR for the period in which tourniquet use was recorded 
as part of the minimum dataset for knee replacement 
surgery (April 2003–December 2003).3 8 We analysed only 
data from primary elective cemented TKRs of which the 
vast majority were performed for osteoarthritis.8 Tourni-
quet use, along with other routinely collected NJR base-
line variables including age at time of surgery, sex and 
American Society of Anaesthesiologists (ASA) classifica-
tion, was analysed to measure independent effects, if any, 
on the rate and timing of all- cause revision.
Kaplan- Meier plots were used to compare time to revi-
sion between groups which underwent TKR with and 
without a tourniquet. Cox regression was performed to 
quantify the difference between the two groups using 
hazard ratios (HR) and to assess the effect of the selected 
baseline variables on risk of all- cause revision. Time to 
revision was measured from date of index surgery to the 
earlier of revision and either date of last follow- up or 
death. All outcomes other than revision were censored. 
Statistical analyses was performed using STATA V.14 Data 
and Analysis Software.
Patient and public involvement
Thirty patients who have undergone TKR were surveyed 
and took part in a focus group to explore their experi-
ences and views towards tourniquet use during their 
surgery. Results revealed that patients believed further 
research on tourniquet use in TKR was important. Implant 
longevity was identified as being a particular concern 
among the patients consulted. Patients contributed to the 
design of this study by helping determine the important 
outcomes and their timing. The results of this research 
will be disseminated to study participants through press 
releases and social media.
RESULTS
We analysed 20 479 primary knee replacement surgery 
cases done between April 2003 and December 2003. Of 
the 406 hospitals listed within the NJR system, 384 had 
returned data (94%).5 The numbers undergoing each 
type of knee replacement surgery, by tourniquet use, are 
given in table 1.
Our analysis is of the 16 974 cases of primary cemented 
TKR. Median follow- up was 12.2 years (IQR 8.4–12.6). 
The baseline characteristics and outcome variables for 
this subset are shown in tables 2 and 3, respectively.
HRs and associated 95% CIs from the univariable 
and multivariable Cox regression models are shown in 
table 4. In the univariable model, there was no evidence 
that the rate at which revisions occur over the study 
period of 13.3 years differs between those undergoing 
surgery with a tourniquet and those undergoing surgery 
without (HR=0.83, 95% CI 0.57 to 1.20, p=0.31). Of the 
selected variables considered, only age at primary surgery 
and gender were significant in the univariable models. 
After adjusting for age at primary surgery, gender and 







Type of replacement implant, n (%)
  TKR cemented 16 132 (83) 842 (73) 16 974 (83)
  TKR uncemented 1238 (6) 228 (20) 1466 (7)
  TKR unclassified (eg, hybrid) 272 (1) 12 (1) 284 (1)
  Unicondylar 1491 (8) 57 (5) 1548 (8)
  Patellofemoral 197 (1) 10 (1) 207 (1)
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primary ASA grade in the multivariable model, the effect 
of tourniquet use on the rate at which revisions occur 
remained largely unchanged (HR=0.82, 95% CI 0.57 to 
1.18, p=0.29). Age at primary surgery remained highly 
significant in the multivariable model and the HRs did 
not change (global test, p<0.001), suggesting that age is 
both a strong and independent predictor of risk of all- 
cause revision. Gender and primary ASA grade did not 
reach statistical significance in the multivariable model, 
suggesting these were not reliable independent predictors 
for risk of all- cause revision. Figure 1 shows Kaplan- Meier 
survival curves for time to all- cause revision in patients 
having TKR surgery with and without a tourniquet.
The difference in percentage unrevised over time 
(cemented TKR with tourniquet minus cemented 
TKR without a tourniquet) is presented, together with 
pointwise confidence intervals, in figure 2. At 5 years, 2.1% 
had undergone revision (95% CI 1.3% to 3.3%) in the 
no- tourniquet group and 1.7% in the tourniquet group 
(95% CI 1.49% to 1.9%). At 10 years, 3.8% had under-
gone revision (95% CI 2.6% to 5.5%) in the no- tourni-
quet group compared with 3.1% in the tourniquet group 
(95% CI 2.8% to 3.4%). Reference lines (indicated red 
in figure 2) indicate where the magnitude of this differ-
ence exceeds 1%. The point estimates of the difference 
(solid blue line) lie within these two limits throughout. 
The upper end of the confidence interval does, however, 
exceed this limit from approximately 3 years onwards. 
Thus, a difference of more than 1% in either direction 
between the tourniquet and no- tourniquet groups cannot 
be ruled out.
DISCUSSION
This analysis used data from the world’s largest TKR audit 
dataset, the NJR, and enabled us to examine the associ-
ation of tourniquet use with all- cause revision surgery 
following primary, elective cemented TKR. Our results 
show similar revision rates between people undergoing 
primary TKR with versus without tourniquet up to 13.3 
years after surgery. The only baseline variable studied 
that showed evidence of an independent effect on the 
risk of revision was age at primary surgery, consistent with 
previous research.14 We also observed that a tourniquet 
was used in 95% of cemented TKRs and 84% of cement-
less TKRs. From this, we infer that tourniquet use might 







Age at primary surgery (years), mean (SD) 71 (9) 72 (9) 71 (9)
Patient gender, n (%)
  Male 6871 (43) 382 (45) 7253 (43)
  Female 9261 (57) 460 (55) 9721 (57)
Primary ASA score, n (%)
  P1: fit and healthy 4421 (28) 235 (28) 4656 (28)
  P2: mild disease not incapacitating 9848 (61) 508 (60) 10 356 (61)
  P3: incapacitating systemic disease 1828 (11) 97 (12) 1925 (11)
  P4: life- threatening disease 35 (<1) 2 (<1) 37 (<1)
ASA, American Society of Anaesthesiologists; TKR, total knee replacement.








  Unrevised 9490 (59) 466 (55) 9956 (59)
  Revised 493 (3) 30 (4) 523 (3)
  Unrevised at time of death 6149 (38) 346 (41) 6495 (38)
Time to outcome in years, median (IQR) 12.2 (8.4–12.6) 12.2 (7.5–12.6) 12.2 (8.4–12.6)
Timing of death, n (%)
  Within 30 days 59 (<1) 3 (<1) 62 (<1)
  31–90 days 42 (<1) 2 (<1) 44 (<1)
  After 90 days 6048 (37) 341 (40) 6389 (38)
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be greater in cemented procedures because of a perceived 
association with better cementation quality. However, this 
association may have arisen by chance.
Our findings indicate that performing TKR with a tour-
niquet is not associated with any clinically meaningful 
difference in the risk of revision compared with surgery 
without a tourniquet. These findings are in keeping with 
two RCTs of 50 and 60 patients who underwent primary 
cemented TKR surgery for osteoarthritis with or without 
the use of a tourniquet. No significant differences in tibial 
component migration was observed at up to 2 years of 
follow- up using radiostereometric analysis.10 11 However, 
patient loss to follow- up in both RCTs resulted in inade-
quate power to detect differences in migration following 
one year, limiting the validity of the study findings to 
predict future revision for loosening to between five and 
ten prosthesis years.15 In contrast, our study has compared 
all- cause revision up to 13.3 years postoperatively and is 
more reflective of real- life practice as it does not limit 
surgeons to a defined surgical technique or other factors 
such as choice of implant or bone cement.
A Cochrane systematic review has shown that using 
a tourniquet for TKR surgery is associated with an 
increased risk of serious adverse events which includes 
venous thromboembolism, infection, reoperation 
and mortality. Other complications including blisters, 
Table 4 HRs and associated 95% CIs from the univariable and multivariable Cox regression models for all- cause revision
Univariable models Multivariable model
HR (95% CI) P value HR (95% CI) P value
Tourniquet used
  No 1.00
0.31
1.00
0.29  Yes 0.83 (0.57 to 1.20) 0.82 (0.57 to 1.18)
Age at primary surgery (years) 0.17 (0.11 to 0.27)




  65–69 0.75 (0.60 to 0.94) 0.74 (0.60 to 0.93)
  70–79 0.41 (0.33 to 0.50) 0.40 (0.32 to 0.49)
  >80 0.18 (0.11 to 0.27) 0.17 (0.11 to 0.27)
Patient gender
  Female 1.00
0.03
1.0
0.21  Male 1.21 (1.01 to 1.43) 1.12 (0.94 to 1.33)
Primary ASA score, n (%)




  P2 0.90 (0.74 to 1.10) 1.08 (0.89 to 1.31)
  P3 1.13 (0.84 to 1.51) 1.39 (1.04 to 1.87)
  P4 1.34 (0.19 to 9.54) 1.61 (0.22 to 11.48)
ASA, American Society of Anaesthesiologists.
Figure 1 Time to all- cause revision by tourniquet use.
Figure 2 Difference in time to revision (TKR with tourniquet 
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haematoma, wound oozing, bruising and nerve palsy 
have also been shown to be more common with tour-
niquet use during TKR surgery, and the devices them-
selves are frequently colonised with bacteria.4 16 17 It 
has been shown that tourniquet use is associated with a 
modest statistically significant reduction in intraopera-
tive blood loss. This may improve the surgical field of 
view, but we are not aware of any published literature 
formally examining this outcome. It is surprising that 
in the absence of any high- quality evidence demon-
strating any likely benefits from using a tourniquet and 
the existing evidence demonstrating their increased 
risk of harm to patients, they continue to have such 
widespread use. Furthermore, there may also be a risk 
of systemic emboli occurring following the deflation 
of a tourniquet.18 Transcranial Doppler ultrasound 
studies have found echogenic material in the Circle 
of Willis after a tourniquet is released and that micro-
embolism can occur even in the absence of a patent 
foramen ovale.19 The potential benefits of tourniquet 
use during TKR surgery must therefore be balanced 
against the risks.
We analysed approximately 17 000 TKR procedures 
from over 384 centres which represent 94% of hospitals 
listed in the NJR at that time.8 Patients were also followed 
up for a median of 12.2 years from their primary proce-
dure, enabling any potential differences in revision rates 
to become more apparent particularly as risk of revision 
for aseptic loosening increases over time.3 We have used 
all- cause revision as the endpoint in our study to miti-
gate risk of misclassification of aseptic loosening within 
the NJR. This is a global outcome that considers other 
failure mechanisms responsible for revision procedure, 
such as prosthetic joint infection, especially considering 
that wound complications have been associated with tour-
niquet usage.4 20 This association is believed to be due 
to a combination of factors including wound ischaemia 
and local inflammation.21 22 The relatively short dura-
tion in which tourniquet data was captured within the 
NJR minimum dataset (April–December 2003) reduces 
biases by time- dependent unknown variables, such as 
cementation techniques and polyethylene modification, 
but does limit the sample size. Conversely, the minimum 
dataset has evolved over time to include established 
risk factors for revision such as Body Mass Index which 
were not captured within version 1 and therefore could 
not be included in our regression analysis.23 24 Further 
limitations also related to application of registry- based 
data include missing data and under- reporting of proce-
dures, preventing the linkage of revision procedures 
to any index procedure.3 25 Due to missing data in our 
dataset, we were not able to perform a subanalysis of 
revision by indication and assess whether rates of peri-
prosthetic patella fractures and secondary patellar resur-
facing differed between the two groups. We acknowledge 
that we did not consider surgery- related factors such 
as implant brand, constraint and bearing type in our 
analysis. This was due to very limited numbers in these 
subgroups which would not add further meaning to our 
analysis. Cement brand and viscosity were also not consid-
ered, but antibiotic content has not been shown to affect 
all- cause revision.26 However, we have collected data that 
encompass the diversity of implant designs and cement 
characteristics across routine practice in the UK, and this 
helps ensure wide generalisability of the results. Another 
limitation is the relatively small sample size of TKR proce-
dures performed without a tourniquet across a large 
number of centres (approximately 150 centres) which 
may have influenced our results due to performance bias 
and confounding by indication.
Due to the defined minimum dataset, we could not 
account for other factors such as use of tranexamic acid 
and application of hypotensive anaesthesia, which are 
used to limit bleeding from cancellous bone ends in an 
attempt to improve the bone- cement interface. Also, 
variability in tourniquet inflation timing, pressures and 
duration introduces heterogeneity within the tourni-
quet group with some surgeons maintaining inflation 
throughout the entire procedure and others only during 
the cementation process. However, the study is reflective 
of real- life routine. Lastly, there is also a risk of bias in our 
cohort study due to confounding by indication although 
an RCT to address this is not feasible given the number 
of participants required to capture small differences in 
implant survival and the extended follow- up required. 
Despite the majority of participants (95%) having surgery 
with a tourniquet, there were a large number in the 
no- tourniquet group, and the baseline patient character-
istics between the two groups are broadly similar.
CONCLUSIONS
Our study has shown a similar risk of revision for primary 
cemented TKRs performed with and without a tourniquet. 
However, we are unable to exclude conclusively a clinically 
important improvement in long- term survival for cemented 
TKRs undertaken with a tourniquet. Surgeons should care-
fully consider this study’s findings as well as the known risks 
and benefits of tourniquet use, and discuss these issues during 
the consent process to allow patients to make an informed 
decision.
Twitter Muhamed M Farhan- Alanie @AlanieMuhamed
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